Arteriosclerosis, Vol 10, 470-476, Copyright © 1990 by American Heart Association
ARTICLES |
Tumor necrosis factor induced release of endothelial cell lipoprotein lipase
U Saxena, LD Witte and IJ Goldberg
Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032.
The major functional pool of lipoprotein lipase (LPL) that hydrolyzes triglycerides in circulating lipoproteins is located on the vascular endothelium. The macrophage-secreted cytokine tumor necrosis factor (TNF), a molecule known to affect endothelial cell functions, was used to test the hypothesis that alterations of endothelial cell metabolism regulate the binding of LPL to these cells. TNF addition induced rapid (maximum release at 45 minutes) dissociation of LPL protein and activity from its binding sites on cultured porcine aortic endothelial cells. LPL release by TNF required endothelial cell metabolic event(s) which involved cell secretion. In addition, LPL release was inhibited by pertussis toxin, suggesting the involvement of guanine nucleotide regulatory protein(s). Addition of arachidonic acid, a molecule known to be released by endothelial cells due to phospholipase A2 activation by TNF treatment, released LPL from the cell surface. Furthermore, direct modulation of cellular phospholipase A2 activity also led to changes in the release of LPL. Our studies demonstrate that alterations in the cellular metabolism of endothelial cells, for example, by TNF, may release functional pools of LPL from the vascular endothelium. This decrease in LPL on endothelial cell surfaces might be involved in the development of hypertriglyceridemia and redirection of energy flow during infections and inflammation.
This article has been cited by other articles:
 |
|
 |
|
  A. Casanovas, N. Parramon, F. de la Cruz, O. Andres, J. Terencio, M. D. Lopez-Tejero, and M. Llobera Retroperitoneal white adipose tissue lipoprotein lipase activity is rapidly down-regulated in response to acute stress J. Lipid Res., April 1, 2007; 48(4): 863 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Sorensen, J. Madsen, K. Kejling, I. Tornoe, O. Nielsen, P. Townsend, F. Poulain, C. H. Nielsen, K. B. M. Reid, S. Hawgood, et al. Surfactant protein D is proatherogenic in mice Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2286 - H2294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Nilsson, S. Jovinge, A. Niemann, R. Reneland, and H. Lithell Relation Between Plasma Tumor Necrosis Factor-{alpha} and Insulin Sensitivity in Elderly Men With Non–Insulin-Dependent Diabetes Mellitus Arterioscler. Thromb. Vasc. Biol., August 1, 1998; 18(8): 1199 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Obunike, S. Paka, S. Pillarisetti, and I. J. Goldberg Lipoprotein Lipase Can Function as a Monocyte Adhesion Protein Arterioscler. Thromb. Vasc. Biol., July 1, 1997; 17(7): 1414 - 1420. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Pillarisetti, L. Paka, A. Sasaki, T. Vanni-Reyes, B. Yin, N. Parthasarathy, W. D. Wagner, and I. J. Goldberg Endothelial Cell Heparanase Modulation of Lipoprotein Lipase Activity. EVIDENCE THAT HEPARAN SULFATE OLIGOSACCHARIDE IS AN EXTRACELLULAR CHAPERONE J. Biol. Chem., June 20, 1997; 272(25): 15753 - 15759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tornvall, G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma Lipoproteins Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1086 - 1093. [Abstract] [Full Text]
|
|